Save over 65% with brand name Mayzent by Novartis.
You may purchase 1 month at a time (as product must be used within 3 months of order)
Non-english packaging - English label and English insert included. Plan in advance - allow us 7 days to ship your medicine.
There are 2 authorized Manufactures for Europe:
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Roonstrasse 25
90429 Nuremberg
Germany
Information about Mayzent (Siponimod)
Mayzent is an oral medication used for the treatment of multiple sclerosis (MS). It is designed to reduce the frequency of MS relapses and delay the progression of physical disability.
Product Highlights
- Indicated for adults with relapsing forms of MS, including active secondary progressive MS.
Key Ingredient
Key Benefits
- Demonstrated effectiveness in reducing relapse rates and slowing disability progression in patients with MS.
- Oral administration and a straightforward dosing schedule improve patient adherence.
- Helps to modulate the immune response while preserving overall immune function.
Direction of Use
- Follow the prescribed titration schedule to reach the maintenance dose.
- Administer the medication once daily, with or without food.
- To achieve the best results, take it at the same time each day.
- Periodic monitoring of liver function and heart rate is recommended.
Safety Concerns
- Common side effects may include headache, elevated liver enzymes, and infections.
- Risk of transient bradycardia (slow heart rate) upon initiation; monitoring is necessary.
- Elevated risk of infections as a result of immune modulation.
Avoid Mayzent (Siponimod) If
- History of hypersensitivity to siponimod or any components of the formulation.
- Not recommended for individuals with significant liver impairment.
- Avoid use in patients with active or serious infections.
